phase ii study of inotuzumab ozogamicin in mrd b-all
Published 1 year ago • 85 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
1:37
phase ii trial of inotuzumab ozogamicin to treat mrd b-all
-
0:43
inotuzumab ozogamicin and blinatumomab prior to and after allohsct in r/r ph all
-
1:27
what is the role of inotuzumab ozogamicin in all
-
4:44
emerging novel approaches for all: inotuzumab ozogamicin
-
4:28
inotuzumab ozogamicin with bosutinib for ph all and cml
-
2:37
the addition of inotuzumab ozogamicin to hyper-cvad blinatumomab in patients with b-all
-
1:45
deciding which patients with mpns are suitable candidates for interferon-based therapy
-
3:04
immunotherapy for frontline treatment of all: inotuzumab ozogamicin and blinatumomab
-
4:38
blinatumomab vs inotuzumab ozogamicin for all
-
2:17
choosing between inotuzumab ozogamicin and blinatumomab in patients with r/r all
-
0:48
the mechanism of action of inotuzumab ozogamicin
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
0:49
what’s next for inotuzumab ozogamicin in all?
-
1:41
the importance of blinatumomab and inotuzumab ozogamicin in treating all
-
4:44
safety and efficacy of blinatumomab and inotuzumab ozogamicin in multiple relapsed all
-
3:03
novel all treatment strategies: inotuzumab ozogamicin
-
1:03
updated results of hyper-cvad and blinatumomab /- inotuzumab ozogamicin in newly-diagnosed b-all
-
1:23
azacitidine and venetoclax /- gemtuzumab ozogamicin in pediatric patients with r/r acute leukemias